We are pleased to share that all subjects in the prophylactic arm of the Phase 2a/b PROTECT clinical trial have received their initial dose of ISLA-101. They will be administered an attenuated strain of dengue fever on 4 October 2024, and we are just weeks away from understanding the potential impact of our drug ISLA-101…

Island has received firm commitments for a two-tranche Placement of A$3.5m at A$0.07 per new share, with one new option attached with every new share issued.

Upstate Medical University is looking for participants for a research study on a new blood test that may detect Lyme disease sooner.

The Central New York Lyme & Tick-Borne Disease Alliance is hosting its third annual Lyme Summit on September 19 & 20 at the CNY Biotech Accelerator in Syracuse, NY. This year we expect an audience of 100-150 healthcare providers from across the region.

Bird flu is a concern mostly for people who work around poultry, says Stephen Thomas, MD, director of the Upstate Global Health Institute. A few cases of bird flu have appeared in humans. He urges vigilance about health and goes over the common symptoms, which include eye redness.